SUMMARY A commercial M antibody capture ELISA kit (Rubenz M) for the detection of rubella specific IgM was evaluated in comparison with M antibody capture radioimmunoassay. A total of 248 sera were evaluated, including sera from cases of primary postnatal rubella, congenital rubella, infectious mononucleosis, and sera which contained rheumatoid factor. No false positive results were obtained but two high positive sera gave Rubenz M values which were below the value recommended as indicative of a positive result. We therefore propose changes in the criteria used for assessing the significance of the results obtained. These changes improve the accuracy of the assay without loss of specificity.
The ability to detect rubella specific IgM is an essential requirement for the serological diagnosis of primary postnatal rubella as sera are often received too late in the evolution of the illness for diagnostic rises in total antibody titre or rubella specific IgG to be shown. Even when diagnostic rises in titre are shown, the demonstration of appreciable concentrations of rubella specific IgM indicates primary rubella rather than reinfection. This latter situation is particularly applicable to subclinical infections as a reinfection appears to be of minimal risk to the fetus.' Furthermore, the detection of rubella specific IgM in neonatal sera has become an established method of diagnosing congenital rubella.
Several techniques are currently available for the detection of rubella specific IgM. Sera may be fractionated by sucrose density gradient ultracentrifugation2 or by gel filtration,3 with haemagglutination inhibition or immunofluorescent detection of rubella specific antibodies being performed on the fractions containing immunoglobulin. These techniques are time consuming, only limited numbers of sera may be evaluated, and technical problems occur such as the presence of residual non-specific inhibitors of haemagglutination. These assays are now being replaced by immunological assays that do not ' Seconded from Dulwich Public Health Laboratory, Dulwich Hospital, East Dulwich Grove, London SE22 8QF. Accepted for publication 11 January 1984 require physical separation of IgM from IgG and IgA.
One variety of such assays is based on the binding of rubella specific IgM from patients' sera to rubella antigen adsorbed to a solid phase. The bound rubella specific IgM is detected by incubation with antihuman antibody labelled radioactively4 or with an enzyme.5 Such assays, however, usually require purified rubella antigen for evaluation of adult sera, although crude rubella antigen is satisfactory for assays performed on neonatal sera. We report our evaluation of the first commercially available rubella specific IgM assay (Rubenz M, Northumbria Biologicals Ltd, Cramlington, UK) of the antibody capture type, which uses an enzyme labelled monoclonal antirubella antibody.
Material and methods

SERA
All sera previously shown to contain rubella specific IgM had been stored at 4°C with added azide. The remaining sera had been stored at -20°C. One hundred sera from patients with primary postnatal rubella were examined. Of these, 87 sera were considered to be high positive and 13 low positive by MACRIA (Table) . A further 12 sera had given an equivocal result by MACRIA. One hundred and two sera were tested from patients with remote primary rubella who gave a history of rubella like symptoms or of recent contact with a rubelliform illness. Rubella specific IgM was not detected by MACRIA in these sera, of which 11 were especially selected as they had raised haemagglutination inhibition titres of >800 IU.
Twelve sera were available from infants with congenital rubella. Eight were positive by MACRIA, two gave equivocal values (collected at 4 months and 1 year of age), and two were negative (collected at 9 months and 1 year of age).
To determine the possible effect of rheumatoid factor, 12 sera were tested which contained high concentrations of rheumatoid factor by latex agglutination and rubella specific IgG detected by radial haemolysis.'9 Ten sera were tested from patients with infectious mononucleosis. Seven of The two sera from cases of congenital rubella which were negative by MACRIA were negative by Rubenz M. Six of the seven strong positive MAC-RIA sera were positive, with the remaining serum giving a CAV 97% of the CAV5. The one MACRIA low positive serum gave a CAV 85% of the CAV5. The two sera from cases of congenital rubella which had given an equivocal result by MACRIA gave, in one case, a CAV of <50% of the CAV5 and in the other a CAV 51% of the CAV5.
All the 12 sera containing rheumatoid factor and rubella specific IgG were negative by Rubenz M, giving CAVs <50% of the CAV5. Nine of the 10 sera from cases of infectious mononucleosis gave similar negative results. The remaining serum had given a MACRIA result of 20 au, but in Rubenz M gave a CAV which was 59% of the CAV,.
Discussion
The Rubenz M assay was convenient and easy to use with the particular advantage of the solid phase comprising polystyrene wells in strips of 12, so enabling a few sera to be tested without wasting expensive materials. The kits are stated to be usable for up to three months and, although no formal shelf life study was performed, the kit worked satisfactorily for at least one month. Results of the assay could be assessed with the unaided eye by comparing test wells with the positive and negative sera control wells. We would, however, recommend spectrophotometric reading of the results to avoid possibly missing low positive results. We did not see false positive results due to bound rheumatoid factor reacting directly with the conjugated antirubella as has been found by others." As no appreciable reactivity was seen with the control wells, it would not appear necessary to perform such controls. Indeed, they are not performed with the MACRIA technique. It may be wise, however, to evaluate each serum in duplicate test wells as this has been shown to minimise any effects of well-to-well variation (personal observation) and would reduce the chance of technical and mechanical error. Such recommendations are being considered by the manufacturers.
The technique of MACRIA for the detection of rubella specific IgM is used routinely in our laboratory and is now well established. It does have a potential sensitivity greater than any other current assay, but the usable sensitivity is limited by values of reactivity of 1-0-3-3 au occurring with sera in which there is usually no supporting evidence for recent primary postnatal or congenital rubella.
Hodgson, Morgan-Capner Indeed, occasional sera have been evaluated in which values of 3-3-10-0 au have not been considered to indicate recent primary or congenital rubella.
MACRIA and Rubenz M are similar in many respects with the only important differences being the nature of the solid phase and the labelling of the monoclonal antirubella with 125I in place of peroxidase. It might therefore be expected that a good correlation would be observed between the results of the two assays. Although there was a good correlation for the presence of rubella specific IgM reactivity, a lack of correlation in the degree of reactivity was seen. Such a lack of correlation between the quantitative results of different assays for the detection of rubella specific IgM is not infrequent (personal observation).
No false positive results were seen when using the criteria recommended by Northumbria Biologicals. Such criteria however, resulted in two strong positive sera being considered negative. These sera had been collected 11 and 24 days after the onset of the rubella rash, were the second sera of a pair showing rubella haemagglutination inhibition seroconversion and had given MACRIA results of 14 and 22 au respectively. They did, however, give CAV values >80% of the CAVs. It is of interest that the latter serum was one of two sera strongly positive by MACRIA which had originally given completely negative results during the initial development of the Rubenz M assay. At this early stage the rubella haemagglutinin antigen used was produced from an RA27/3 strain of rubella virus. On using the Judith strain, both sera became reactive in Rubenz M so necessitating a change in the rubella haemagglutinin antigen used in the assay.
If the CAV value taken to indicate positivity was reduced to 80% CAV5, a further four of the low positive sera, one of the congenital rubella high positive sera, and the congenital rubella low positive serum became positive. As all 102 negative sera and the 12 sera containing rheumatoid factor gave In conclusion, Rubenz M would appear to be an ideal assay for the detection of rubella specific IgM for laboratories not equipped to perform MACRIA as, from our evaluation, it has appropriate sensitivity and specificity. As for all assays for the detection of rubella specific IgM, however, the final interpretation of the result obtained will depend on a critical appraisal of all clinical and serological data available and the above recommended criteria may need reassessment when considerable " in use" experience has been obtained.
